Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.